Drug Shortage Report for CHOLESTYRAMINE-ODAN

Last updated on 2020-01-09 History
Report ID 96259
Drug Identification Number 02455609
Brand name CHOLESTYRAMINE-ODAN
Common or Proper name Cholestyramine for Oral Suspension, USP
Company Name ODAN LABORATORIES LTD
Market Status MARKETED
Active Ingredient(s) CHOLESTYRAMINE RESIN
Strength(s) 4G
Dosage form(s) POWDER FOR SUSPENSION
Route of administration ORAL
Packaging size 4g
ATC code C10AC
ATC description LIPID MODIFYING AGENTS, PLAIN
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2019-10-11
Estimated end date 2020-01-10
Actual end date 2020-01-08
Shortage status Resolved
Updated date 2020-01-09
Company comments
Health Canada comments
Company contact information info@odanlab.com Tel.: 1-800-387-9342 Fax: 1-800-329-6326

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2020-01-09 English Compare
v10 2020-01-08 French Compare
v9 2020-01-08 English Compare
v8 2019-12-30 French Compare
v7 2019-12-30 English Compare
v6 2019-12-18 French Compare
v5 2019-12-18 English Compare
v4 2019-10-12 English Compare
v3 2019-10-11 French Compare
v2 2019-10-11 English Compare
v1 2019-10-11 English Compare